𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sulforaphane inhibited expression of hypoxia-inducible factor-1α in human tongue squamous cancer cells and prostate cancer cells

✍ Scribed by Hua Yao; Huiming Wang; Zhuo Zhang; Bing-Hua Jiang; Jia Luo; Xianglin Shi

Publisher
John Wiley and Sons
Year
2008
Tongue
French
Weight
399 KB
Volume
123
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Previous studies show that a number of natural compounds from our diet have anticancer effects. Sulforaphane is the most characterized isothiocyanates (ITCs), which are identified in cruciferous vegetables. Sulforaphane is viewed as a conceptually promising agent in cancer prevention. Because of its ability to induce cancer cell apoptosis, it inhibits progression of benign tumors to malignant tumors and interrupts metastasis. However, the effect of sulforaphane on tongue cancer cell proliferation has not yet been reported, and the mechanisms that sulforaphane inhibits cancer development are still unclear. Hypoxia‐inducible factor 1 (HIF‐1) expression is associated with tumorigenesis and angiogenesis. It regulates the expression of many genes including vascular endothelial growth factor (VEGF), inducible nitric oxide synthase, and lactate dehydrogenase A. In our study, we investigated the effects of sulforaphane on expression of hypoxia‐inducible factor‐1α (HIF‐1α), which was overexpressed in many human malignant tumors, human tongue squamous cell carcinoma and prostate cancer DU145 cells. Sulforaphane inhibited hypoxia induced expression of HIF‐1α via inhibiting synthesis of HIF‐1α. Sulforaphane was also found to inhibit hypoxia induced HIF‐1α expression through activating JNK and ERK signaling pathways, but not AKT pathway. Inhibition of HIF‐1α by sulforaphane resulted in decreasing expression of VEGF. Taken together, these results suggest that sulforaphane is an effective chemopreventive compound against tongue cancers and prostate cell angiogenesis in vitro, and that the HIF‐1α target provides a new sight into the mechanisms of sulforaphane's inhibition against tumor cell proliferation. © 2008 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Thrombin induces expression of twist and
Thrombin induces expression of twist and cell motility via the hypoxia-inducible factor-1α translational pathway in colorectal cancer cells
✍ Li-Hsun Chang; Chun-Han Chen; Der-Yi Huang; Hui-Chen Pai; Shiow-Lin Pan; Che-Min 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB

## Abstract Deep vein thrombosis associated with advanced cancer is known as Trousseau's syndrome. We hypothesized that thrombin, an activator of protease‐activated receptor (PAR)‐1 and PAR‐4 contributes to tumor metastasis. In this study, we demonstrated that thrombin and the PAR‐1 activating pept

Effect of inducible expression of HIF-1α
Effect of inducible expression of HIF-1α on prostate cancer cell in MPPa-PDT
✍ Y.Y. Tian; F. Kong; X. Tian; Q. Guo; F.A. Cui 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

Photodynamic therapy (PDT) is a promising treatment on neoplastic pathologic tissues, which involves the administration of a photosensitizing agent followed by exposure of the tissue to visible non-thermal light. In our previous findings MPPa was showed to be a good photosensitizer candidature, beca

Lysophosphatidic acid activates telomera
Lysophosphatidic acid activates telomerase in ovarian cancer cells through hypoxia-inducible factor-1α and the PI3K pathway
✍ Kun Yang; Danhua Zheng; Xiaoli Deng; Lin Bai; Yan Xu; Yu-Sheng Cong 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 267 KB

## Abstract Telomerase is reactivated in over 90% of tumors and plays critical roles in tumor progression. The mechanisms by which telomerase is up‐regulated in cancer cells are poorly understood. Here we showed that a bioactive lipid, lysophophatidic acid (LPA), up‐regulated the expression of huma

Hypoxia-inducible factor-1α in non small
Hypoxia-inducible factor-1α in non small cell lung cancer: Relation to growth factor, protease and apoptosis pathways
✍ Daniel E.B. Swinson; J. Louise Jones; Giles Cox; Donna Richardson; Adrian L. Har 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 199 KB

## Abstract Hypoxia‐inducible factor (HIF)‐1α is the regulatory subunit of HIF‐1 that is stabilized under hypoxic conditions. Under different circumstances, HIF‐1α may promote both tumorigenesis and apoptosis. There is conflicting data on the importance of HIF‐1α as a prognostic factor. This study

Novel surface expression of reticulocalb
Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-α
✍ Carlton R. Cooper; Bianca Graves; Freddie Pruitt; Hassan Chaib; Jill E. Lynch; A 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB

## Abstract An unbiased cDNA expression phage library derived from bone‐marrow endothelial cells was used to identify novel surface adhesion molecules that might participate in metastasis. Herein we report that reticulocalbin 1 (RCN1) is a cell surface‐associated protein on both endothelial (EC) an

Raloxifene induces cell death and inhibi
Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptorα and β
✍ V. Rossi; G. Bellastella; C. De Rosa; C. Abbondanza; D. Visconti; L. Maione; P. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

## Abstract Raloxifene (RAL), a selective estrogen receptor (ER) modulator (SERM) seems to induce apoptosis in both androgen‐dependent and ‐independent prostate cell (PC) lines via activation of ERβ and an antagonistic effect on ERα. In this study, we evaluated the effects of RAL on epithelial PC g